Aaron Cowen’s CalciMedica CALC Stock Holding History

Aaron Cowen’s Portfolio CALC Stock Details CALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-7,836	Closed	-$1.39M	–	109
2020 Q3	$1.39M	Buy	+7,836	New	+$1.63M	0.03%	84

Other funds holding CALC

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Aaron Cowen's CALC Position: Q4 2020 in Review

Aaron Cowen sold out of CalciMedica (CALC) in Q4 2020, closing a stake of 7,836 shares — an estimated $1.39M sold.

Aaron Cowen first reported a position in CALC in Q3 2020 and held it in 1 quarter. The position peaked at $1.39M in Q3 2020. 33 funds tracked by Wall St. Rank hold CALC as of Q4 2020.

Aaron Cowen reported no remaining CalciMedica position as of Q4 2020 after selling out during the quarter.
Aaron Cowen sold 7,836 CalciMedica shares in Q4 2020, an estimated $1.39M.
Aaron Cowen first reported a position in CalciMedica in Q3 2020 and held it in 1 quarter.
Aaron Cowen's CalciMedica position peaked at $1.39M in Q3 2020.
33 funds tracked by Wall St. Rank held CalciMedica as of Q4 2020.

Based on Suvretta Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.